...
首页> 外文期刊>Bioconjugate Chemistry >Impact of Multiple Negative Charges on Blood Clearance and Biodistribution Characteristics of Tc-Labeled Dimeric Cyclic RGD Peptides
【24h】

Impact of Multiple Negative Charges on Blood Clearance and Biodistribution Characteristics of Tc-Labeled Dimeric Cyclic RGD Peptides

机译:多个负电荷对Tc标签的二聚体环状RGD肽的血液清除和生物分布特征的影响

获取原文
获取原文并翻译 | 示例

摘要

This study sought to evaluate the impact of multiple negative charges on blood clearance kinetics and biodistribution properties of ~(99m)Tc-labeled RGD peptide dimers. Bioconjugates HYNIC-P6G-RGD2 and HYNIC-P6D-RGD2 were prepared by reacting P6G- RGD2 and P6D-RGD2, respectively, with excess HYNIC-OSu in the presence of diisopropylefhylamine. Their IC_(50) values were determined to be 31 ± 5 and 41 ± 6 nM, respectively, against ~(125)I-echistatin bound to U87MG glioma cells in a whole-cell displacement assay. Complexes [~(99m)Tc(HYNIC-P6G-RGD2)(tricine)(TPPTS)] (~(99m)Tc-P6G-RGD2) and [~(99m)Tc(HYNIC-P6D-RGD2)(tricine)(TPPTS)] (~(99m)Tc-P6D-RGD2) were prepared ,in high radiochemical purity (RCP > 95%) and specific activity (37—110 GBq/μmol). They were evaluated in athymic nude mice bearing U87MG glioma xenografts for their biodistribution. The most significant difference between ~(99m)Tc-P6D-RGD2 and ~(99m)Tc-P6G-RGD2 was their blood radioactivity levels and tumor uptake. The initial blood radioactivity level for ~(99m)Tc-P6D- RGD2 (4.71 ±1.00%ID/g) was ~SX higher than that of ~(99m)Tc-P6G-RGD2 (0.88 ± 0.05%ID/ g), but this difference disappeared at 60 min p.i. ~(99m)Tc-P6D-RGD2 had much lower tumor uptake .(2.26-3.11%ID/g) than ~(99m)Tc-P6G-RGD2 (7.82-9.27%ID/g) over a 2 h period. Since HYNIC-P6D-RGD2 and HYNIC- P6G-RGD2. shared a similar,integrin α_vβ3 binding affinity (41 ± 6 nM versus 31 ± S nM), the difference in their blood activity and tumor uptake is most'likely related to the nine negative charges and high protein binding of ~(99m)Tc-P6D-RGD2. Despite its low uptake in U87MG tumors, the tumor uptake of ~(99m)Tc-P6D-RGD2 was integrin a/3-specific. SPECT/CT studies were performed using ~(99m)Tc-P6G-RGDj in athymic nude mice bearing U87MG glioma and MDA-MB-231 breast cancer xenografts. The SPECT/CT data demonstrated the tumor-targeting capability of ~(99m)Tc-PeG-RGD2, and its tumor uptake depends on the integrin α_vβ3 expression levels on tumor cells and neovasculature. It was concluded that the multiple negative charges have a significant impact on the blood clearance kinetics and tumor uptake of ~(99m)Tc-labeled dimeric cyclic RGD peptides.
机译:这项研究试图评估多个负电荷对〜(99m)Tc标记的RGD肽二聚体的血液清除动力学和生物分布特性的影响。通过在二异丙基乙胺的存在下分别使P6G-RGD2和P6D-RGD2与过量的HYNIC-OSu反应,制备生物共轭物HYNIC-P6G-RGD2和HYNIC-P6D-RGD2。在全细胞置换试验中,针对与U87MG胶质瘤细胞结合的〜(125)I-伊斯汀抑制素,其IC_(50)值分别确定为31±5和41±6 nM。配合物[〜(99m)Tc(HYNIC-P6G-RGD2)(三氢甲烷)(TPPTS)](〜(99m)Tc-P6G-RGD2)和[〜(99m)Tc(HYNIC-P6D-RGD2)(三氢呋喃)( [TPPTS)](〜(99m)Tc-P6D-RGD2)的制备具有较高的放射化学纯度(RCP> 95%)和比活(37-110 GBq /μmol)。在携带U87MG胶质瘤异种移植物的无胸腺裸鼠中评估了它们的生物分布。 〜(99m)Tc-P6D-RGD2和〜(99m)Tc-P6G-RGD2之间最显着的区别是它们的血液放射性水平和肿瘤吸收。 〜(99m)Tc-P6D-RGD2的初始血液放射性水平(4.71±1.00%ID / g)比〜(99m)Tc-P6G-RGD2的初始血液放射性水平(0.88±0.05%ID / g)高〜SX,但这种差异在pi 60分钟时消失了〜(99m)Tc-P6D-RGD2在2小时内的肿瘤摄取率(2.26-3.11%ID / g)比〜(99m)Tc-P6G-RGD2(7.82-9.27%ID / g)低得多。从HYNIC-P6D-RGD2和HYNIC-P6G-RGD2开始。具有相似的整联蛋白α_vβ3结合亲和力(41±6 nM对31±S nM),其血液活性和肿瘤摄取差异最可能与〜(99m)Tc-的九个负电荷和高蛋白结合有关P6D-RGD2。尽管其在U87MG肿瘤中的摄取较低,但〜(99m)Tc-P6D-RGD2的肿瘤摄取还是整联蛋白a / 3特异性的。使用〜(99m)Tc-P6G-RGDj在携带U87MG神经胶质瘤和MDA-MB-231乳腺癌异种移植的无胸腺裸鼠中进行SPECT / CT研究。 SPECT / CT数据证明了〜(99m)Tc-PeG-RGD2的肿瘤靶向能力,其肿瘤摄取取决于肿瘤细胞和新脉管系统上整联蛋白α_vβ3的表达水平。结论是,多个负电荷对〜(99m)Tc标记的二聚环RGD肽的血液清除动力学和肿瘤吸收具有显着影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号